Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

2.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
Urinary Bladder01:23

Urinary Bladder

2.0K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loneliness in prostate cancer survivors.

Journal of cancer research and clinical oncology·2026
Same author

Various dimensions of sexual self-concept in middle-aged men after vasectomy: a matched analysis.

BJU international·2026
Same author

[Perceived autonomy of long-term prostate cancer survivors].

Urologie (Heidelberg, Germany)·2026
Same author

Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review.

European journal of cancer (Oxford, England : 1990)·2026
Same author

MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial.

European urology oncology·2026
Same author

Assessment of nephrotoxicity following lutetium-177 PSMA I&T radioligand therapy: a comparative study with docetaxel chemotherapy.

European journal of nuclear medicine and molecular imaging·2026
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Related Experiment Video

Updated: Nov 5, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.4K

[Muscle-invasive bladder cancer].

Jakob Büchler1, Jürgen E Gschwend2, Margitta Retz2

  • 1Klinik und Poliklinik für Urologie, Universitätsklinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Deutschland. jakob.buechler@tum.de.

Der Urologe. Ausg. A
|May 20, 2021
PubMed
Summary
This summary is machine-generated.

This case study applies German S3 guideline recommendations for bladder cancer treatment. It explores options from bladder preservation to radical cystectomy for invasive transitional cell carcinoma.

Keywords:
BCGChemotherapy, neoadjuvantCystectomyTransurethral resectionUrinary bladder neoplasmsUrinary division

More Related Videos

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.7K
3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

9.2K

Related Experiment Videos

Last Updated: Nov 5, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.4K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.7K
3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

9.2K

Area of Science:

  • Oncology
  • Urology

Background:

  • Bladder cancer presents complex treatment challenges.
  • Treatment decisions are guided by cancer stage and patient factors.

Purpose of the Study:

  • To illustrate the application of the German S3 guideline for bladder cancer.
  • To discuss treatment options for invasive transitional cell carcinoma using a case study.

Main Methods:

  • A fictitious case study of a patient with invasive transitional cell carcinoma was developed.
  • Treatment recommendations from the German S3 guideline were applied.
  • Current literature on bladder cancer treatment was reviewed.

Main Results:

  • Treatment options discussed include bladder preservation and radical cystectomy.
  • Neoadjuvant chemotherapy in conjunction with radical cystectomy was considered.
  • The case study highlights the decision-making process based on the guideline.

Conclusions:

  • The German S3 guideline provides a framework for managing invasive bladder cancer.
  • A multidisciplinary approach is essential for optimal treatment selection.
  • Individualized treatment plans are crucial for effective bladder cancer care.